81 related articles for article (PubMed ID: 5387389)
21. Piperazine protects the rat heart against sudden cardiac death from barium chloride-induced ventricular fibrillation.
Ghasi S
Am J Ther; 2008; 15(2):119-25. PubMed ID: 18356631
[TBL] [Abstract][Full Text] [Related]
22. [Cardiac action of beta-blocking agents. IV. Comparison of the capacity of propranolol and of L-(4-nitrophenyl)-2-isopropyl-amino-ethanol to prevent the electrocardiographic effects of intravenous injection of pitressin in rats].
Razzaboni G; Setti L; Vitolo A
Boll Soc Ital Biol Sper; 1968 Aug; 44(16):1318-9. PubMed ID: 5732783
[No Abstract] [Full Text] [Related]
23. Effects and mechanism of action of trimazosin on coronary and left ventricular dynamics in conscious dogs.
Macho P; Vatner SF
J Pharmacol Exp Ther; 1981 May; 217(2):333-9. PubMed ID: 7229975
[No Abstract] [Full Text] [Related]
24. [Validity of the transcutaneous PO2-measurement during pharmacologically induced changes of skin perfusion (author's transl)].
Wendling P; Füssinger R; Schmidt HD; Stosseck K
Anaesthesist; 1982 Mar; 31(3):135-8. PubMed ID: 7072928
[TBL] [Abstract][Full Text] [Related]
25. Regionally different vascular response to vasoactive substances in the remodelled infarcted rat heart; aberrant vasculature in the infarct scar.
Kalkman EA; van Haren P; Saxena PR; Schoemaker RG
J Mol Cell Cardiol; 1997 May; 29(5):1487-97. PubMed ID: 9201633
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
Gao M; Mock BH; Hutchins GD; Zheng QH
Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585
[TBL] [Abstract][Full Text] [Related]
27. Haemodynamic effects of vasoactive agents following chronic state of high cardiac output in anaesthetized rats.
Guo L; Tabrizchi R
Eur J Pharmacol; 2008 May; 586(1-3):266-74. PubMed ID: 18367170
[TBL] [Abstract][Full Text] [Related]
28. The disappeance of adenosine in dog blood after low oral doses of lidoflazine (0.31-5 mg-kg).
Van Belle H
Eur J Pharmacol; 1970 May; 10(2):290-2. PubMed ID: 5446381
[No Abstract] [Full Text] [Related]
29. Does nitric oxide participate in the mechanism of action of dotarizine?
Petkov VD; Belcheva S; Konstantinova E; Petkov VV
Acta Physiol Pharmacol Bulg; 1998; 23(3-4):93-9. PubMed ID: 10672335
[TBL] [Abstract][Full Text] [Related]
30. Cardiac and haemodynamic effects of intravenous administrations of flunarizine in closed-chest anaesthetized mongrel dogs.
Kubo K; Van de Water A; Wouters L; Xhonneux R; Reneman RS
Arzneimittelforschung; 1984; 34(4):434-9. PubMed ID: 6430305
[TBL] [Abstract][Full Text] [Related]
31. The effects of sildenafil on heart rate variability in healthy subjects.
Siepmann M; Rauh R; Dill O; Agelink MW; Mueck-Weymann M
J Cardiovasc Pharmacol; 2007 Nov; 50(5):598-600. PubMed ID: 18030072
[TBL] [Abstract][Full Text] [Related]
32. The pharmacodynamics of bucainide (RHC G233): pharmacokinetic parameters and relationship between plasma levels and the effect on the electrocardiogram in the dog.
Grebow P; Feeney W; Johnston M; Lettieri J; Li H; Magnien E; O'Brien P; Swillo R; Weinryb I; Wolf P; Marsiglia JC
Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):407-21. PubMed ID: 7268191
[TBL] [Abstract][Full Text] [Related]
33. Cinepazet relaxation of aortic strips from normal and spontaneously hypertensive rats.
Levy JV
Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):205-8. PubMed ID: 7403676
[TBL] [Abstract][Full Text] [Related]
34. Lidoflazine in the treatment of chronic atrial fibrillation.
Piessens J; Kesteloot H; De Geest H
Arzneimittelforschung; 1970 Mar; 20(3):355-8. PubMed ID: 5467509
[No Abstract] [Full Text] [Related]
35. Effect of magnesium asparaginate on the coronary circulation.
Görög P; Ezer E; Szporny L
Arzneimittelforschung; 1966 Nov; 16(11):1488-90. PubMed ID: 6014963
[No Abstract] [Full Text] [Related]
36. [The effect of hexabendin on oxygen consumption, energeties and substrate metabolism of the heart. II. Studies with intravenous infusions].
Kraupp O; Wolner E; Adler-Kastner L; Chirikdjian JJ; Ploszczanski B; Tuisl E
Arzneimittelforschung; 1966 Jun; 16(6):697-705. PubMed ID: 6014578
[No Abstract] [Full Text] [Related]
37. The effect of sildenafil on electrostimulation-induced erection in the rat model.
Ueno N; Iwamoto Y; Segawa N; Kinoshita M; Ueda H; Katsuoka Y
Int J Impot Res; 2002 Aug; 14(4):251-5. PubMed ID: 12152113
[TBL] [Abstract][Full Text] [Related]
38. [Myocardial cytoprotection with trimetazidine in patients with ischemic heart disease during surgical stress].
Afanas'eva IV; Goncharova LL; Miroshnichenko AG; Petrash VV; Pokrovskaia LA
Vestn Khir Im I I Grek; 1999; 158(5):34-7. PubMed ID: 10645577
[TBL] [Abstract][Full Text] [Related]
39. Effect of pitressin on the isolated perfused rabbit heart.
HANSON KM; JOHNSON JA
Am J Physiol; 1957 Jul; 190(1):81-3. PubMed ID: 13458414
[No Abstract] [Full Text] [Related]
40. Effects of propranolol and some coronary vasodilators on digitalis-induced arrhythmia and hyperkalemia in the dog.
Hayakawa T
Kumamoto Med J; 1968 Dec; 21(4):156-68. PubMed ID: 5730678
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
